DaVita Inc. (DVA.N)
60.38USD
14 Dec 2009
$0.84 (+1.41%)
$59.54
$59.89
$60.46
$59.76
292,200
1,195,631
$61.94
$41.21
DVA.N
About
Overall
| Beta: | 0.45 |
| Market Cap (Mil.): | $6,170.84 |
| Shares Outstanding (Mil.): | 102.20 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| DVA.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 15.32 | 10.56 | 4.61 |
| EPS (TTM): | 16.48 | -- | -- |
| ROI: | 7.53 | 4.16 | 2.81 |
| ROE: | 20.34 | 8.48 | 4.10 |
UPDATE 1-FMC prepares successor for CEO post
* Says the role will prepare Powell to succeed CEO Lipps
UPDATE 1-DaVita third-quarter profit rises 18 percent
LOS ANGELES, Nov 3 (Reuters) - DaVita Inc , the biggest U.S. operator of dialysis clinics, reported a better-than-expected 18 percent jump in third-quarter profit on Tuesday as treatment volume increased.
UPDATE 2-Fresenius Q3 profit up on higher generic drug sales
* Q3 adjusted net income 128 mln euros, vs forecast 123 mln
UPDATE 1-DaVita second-quarter profit rises 11 percent
LOS ANGELES, Aug 4 (Reuters) - DaVita Inc , the biggest U.S. operator of dialysis clinics, reported a better-than-expected 11 percent jump in second-quarter profit on Tuesday as treatment volume increased.
UPDATE 1-FMC Q2 net gains on higher revenue per treatment
FRANKFURT, Aug 4 (Reuters) - Fresenius Medical Care's second-quarter net income rose 5 percent, more than expected, as patient numbers increased and revenue per treatment in its biggest market rose, FMC said on Tuesday.
UPDATE 1-DaVita says faces no charges after U.S. ends probe
CHICAGO, May 4 (Reuters) - DaVita Inc , an operator of dialysis centers, said on Monday it will face no charges, fines or policy changes after the U.S. government concluded a nearly five-year investigation into its business practices.
UPDATE 1-FMC Q1 profits up, confirms outlook
FRANKFURT, April 30 (Reuters) - Dialysis provider Fresenius Medical Care's first-quarter net income rose 7 percent as patient numbers increased, FMC said on Thursday.
UPDATE 1-FMC sees further profit growth in 2009
FRANKFURT, Feb 19 (Reuters) - Dialysis provider Fresenius Medical Care aims to increase net profits further this year after reporting an earnings gain in the fourth quarter, it said on Thursday.
US RESEARCH SUMMARY-Non-S&P 500 Feb 12 2237 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 12 1725 GMT
Following is a summary of research actions on non-S&P 500 companies reported
Competitors
| Price | Change | |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA (FMEG.DE) | €36.96 | +0.15 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
